PortfoliosLab logoPortfoliosLab logo
RVMD vs. SHW
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RVMD vs. SHW - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revolution Medicines, Inc. (RVMD) and The Sherwin-Williams Company (SHW). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RVMD achieves a 100.95% return, which is significantly higher than SHW's -0.69% return.


RVMD

1D
4.02%
1M
9.89%
YTD
100.95%
6M
102.61%
1Y
294.33%
3Y*
86.64%
5Y*
35.73%
10Y*

SHW

1D
0.93%
1M
6.99%
YTD
-0.69%
6M
-2.03%
1Y
-3.77%
3Y*
9.88%
5Y*
4.52%
10Y*
13.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RVMD vs. SHW - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
RVMD
Revolution Medicines, Inc.
100.95%82.10%52.51%20.40%-5.36%-36.42%40.34%
SHW
The Sherwin-Williams Company
-0.69%-3.83%9.90%32.73%-31.96%44.90%27.80%

Correlation

The correlation between RVMD and SHW is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (All Time)
Calculated using the full available price history since Feb 13, 2020

0.22

Fundamentals

Market Cap

RVMD:

$31.71B

SHW:

$79.45B

EPS

RVMD:

-$7.17

SHW:

$10.42

PB Ratio

RVMD:

21.14

SHW:

17.93

Total Revenue (TTM)

RVMD:

$0.00

SHW:

$23.94B

Gross Profit (TTM)

RVMD:

-$4.70M

SHW:

$11.76B

EBITDA (TTM)

RVMD:

-$1.34B

SHW:

$4.29B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RVMD vs. SHW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVMD
RVMD Risk / Return Rank: 9898
Overall Rank
RVMD Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
RVMD Sortino Ratio Rank: 9999
Sortino Ratio Rank
RVMD Omega Ratio Rank: 9898
Omega Ratio Rank
RVMD Calmar Ratio Rank: 9898
Calmar Ratio Rank
RVMD Martin Ratio Rank: 9898
Martin Ratio Rank

SHW
SHW Risk / Return Rank: 3434
Overall Rank
SHW Sharpe Ratio Rank: 3636
Sharpe Ratio Rank
SHW Sortino Ratio Rank: 3030
Sortino Ratio Rank
SHW Omega Ratio Rank: 3030
Omega Ratio Rank
SHW Calmar Ratio Rank: 3636
Calmar Ratio Rank
SHW Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RVMD vs. SHW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines, Inc. (RVMD) and The Sherwin-Williams Company (SHW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RVMDSHWDifference
Sharpe ratioReturn per unit of total volatility

+4.57

Sortino ratioReturn per unit of downside risk

+5.64

Omega ratioGain probability vs. loss probability

1.78

0.99

+0.79

Calmar ratioReturn relative to maximum drawdown

11.88

-0.18

+12.06

Martin ratioReturn relative to average drawdown

28.48

-0.37

+28.85

RVMD vs. SHW - Sharpe Ratio Comparison

The current RVMD Sharpe Ratio is 4.41, which is higher than the SHW Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of RVMD and SHW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RVMD vs. SHW - Drawdown Comparison

The maximum RVMD drawdown since its inception was -73.29%, which is greater than SHW's maximum drawdown of -52.02%. Use the drawdown chart below to compare losses from any high point for RVMD and SHW.


Loading charts...

Drawdown Indicators


RVMDSHWDifference

Max Drawdown

Largest peak-to-trough decline

-73.29%

-52.02%

-21.27%

Max Drawdown (1Y)

Largest decline over 1 year

-24.95%

-21.36%

-3.59%

Max Drawdown (3Y)

Largest decline over 3 years

-48.63%

-25.69%

-22.94%

Max Drawdown (5Y)

Largest decline over 5 years

-57.95%

-42.46%

-15.49%

Max Drawdown (10Y)

Largest decline over 10 years

-42.46%

Current Drawdown

Current decline from peak

-2.21%

-18.78%

+16.57%

Average Drawdown

Average peak-to-trough decline

-35.66%

-11.63%

-24.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

10.57%

10.26%

+0.31%

Volatility

RVMD vs. SHW - Volatility Comparison

Revolution Medicines, Inc. (RVMD) has a higher volatility of 13.97% compared to The Sherwin-Williams Company (SHW) at 9.00%. This indicates that RVMD's price experiences larger fluctuations and is considered to be riskier than SHW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RVMDSHWDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.97%

9.00%

+4.97%

Volatility (6M)

Calculated over the trailing 6-month period

55.20%

19.26%

+35.94%

Volatility (1Y)

Calculated over the trailing 1-year period

67.30%

24.88%

+42.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.58%

26.27%

+36.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

65.75%

26.60%

+39.15%

Dividends

RVMD vs. SHW - Dividend Comparison

RVMD has not paid dividends to shareholders, while SHW's dividend yield for the trailing twelve months is around 0.99%.


PositionTTM20252024202320222021202020192018201720162015
RVMD
Revolution Medicines, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SHW
The Sherwin-Williams Company
0.99%0.98%0.84%0.78%1.01%0.62%0.73%0.77%0.87%0.83%1.25%1.03%

Financials

RVMD vs. SHW - Financials Comparison

This section allows you to compare key financial metrics between Revolution Medicines, Inc. and The Sherwin-Williams Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B202220232024202520260
5.67B
(RVMD) Total Revenue
(SHW) Total Revenue
Values in USD except per share items

Frequently Asked Questions


RVMD and SHW have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RVMD has higher volatility (13.97%) compared to SHW (9.00%). In terms of maximum drawdown, RVMD dropped -73.29% vs SHW's -52.02%.

RVMD currently has the higher Sharpe Ratio (4.41 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RVMD and SHW

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer